Wearable 2-week ECG to detect atrial fibrillation

Randomized crossover trial comparing a wearable 2-week ECG versus standard 24-hour ECG to detect a recurrence of atrial fibrillation after the catheter ablation - hitoe-2

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs032180018

Enrollment

Registered

2018-09-12

Start date

2018-10-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation

Interventions

Wearable ECG monitoring

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent an initial catheter ablation for atrial fibrillation

Exclusion criteria

Exclusion criteria: 1) Allergies 2) Very sensitive skin to adhesive tape with a history of redness, erosion and scar 3) Cardiac implantable electronic devices

Design outcomes

Primary

Measure	Time frame
Detection of recurrent atrial fibrillation	—

Secondary

Measure	Time frame
Comfort scale of the materials	—

Contacts

Public ContactTakeshi Machino

University of Tsukuba Hospital

machino@md.tsukuba.ac.jp+81-29-853-3143

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026